// App-Quantinova.ai

6705 : An integrated in vitro and in vivo approach providing insights in immune modulation

Researchers

Presenter

  • Shilina Roman

Principal Investigators

  • Julia Schler

  • Sanne Holt

  • Jeroen DeGroot

  • Omar Aziz

  • Ian Waddell

Medical Centers

  • Charles River Laboratories, Harlow, United Kingdom.

  • Charles River Laboratories, Freiburg, Germany.

  • Charles River Laboratories, Inc., Harlow, Netherlands

  • Charles River Laboratories, Inc., Harlow, Netherlands

Locations

  • United Kingdom

  • Germany

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • T-cell receptor

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved